Market

MindSEED ApS uses EEG technology in behind-the-ear wearables to revolutionize epilepsy care by providing non-invasive monitoring for early detection and intervention of non-convulsive seizures.

Who do we help

Revolutionizing epilepsy with MindSEED

At MindSEED ApS, we are revolutionizing epilepsy care with cutting-edge technology that combines EEG with behind-the-ear wearable devices for decentralized monitoring of temporal lobe brain activity. Our mission is to provide the next generation of wearable EEG medical devices with advances in digital diagnostics, enabling patients and doctors to monitor brain activity in a non-invasive and user-friendly manner.

Epilepsy is a neurological disorder that affects around 1% of the global population, with seizures being its most recognizable symptom. The market for EEG and related accessories, which are used to diagnose and monitor epilepsy, is valued at Euro 1.25 billion and is projected to grow at a CAGR of 7% until 2028. Our innovative technology is poised to capture a significant share of this market by addressing a significant unmet need.
Non-convulsive seizures, such as childhood absence seizures (CAS), are often under-diagnosed or misdiagnosed due to their subtle nature. CAS can have a significant impact on a child’s ability to learn, making early detection and intervention critical for successful treatment outcomes. With 10% of epilepsy cases occurring in youth, the total addressable market for our technology is projected to be 0.1%, or 8 million patients.

Our device is designed with state-of-the-art sensors that detect and interpret brain activity in real-time, providing valuable and actionable insights for both patients and care providers. The placement of our EEG electrodes behind the ear is a novel approach that has been validated in a clinical setting through a single-patient study at the Center for Neurology in Aarhus. This study found a 78% data fidelity compared to the EEG 10-20 golden standard and reference instrument.

Our technology incorporates machine learning to accurately identify the onset of seizures, providing personalized and accurate digital diagnostics with over 95% accuracy. The data is then collected and stored in the European Data Format (EDF) for seamless integration into current health platforms.
By providing better care for an underserved group, we are making a tangible impact on two of the United Nations’ Sustainable Development Goals: SDG3 (good health and well-being) and SDG4 (quality education). Our device is designed to be non-stigmatizing and user-friendly, making it an accessible solution for children and youth who need it most.

Our team brings years of expertise in medical devices, consumer electronics, and manufacturing to ensure that the needs of both patients and healthcare providers are met. We are committed to developing a device that is comfortable, easy to use, and non-stigmatizing, transforming how patient care is given and developed.
Join us on our mission to transform epilepsy care and improve patient outcomes. Contact us today to learn more about how our innovative technology can help make a difference in the lives of millions of patients worldwide.

What to know more?

Then let’s get in touch